Patients with mild to moderate dry eye disease will be randomized to receive either NovaTears® or Hydrabak® eye drops as control.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
48
Topical eye drops for lubrication of the ocular surface
Eye drops
Medical University of Vienna, Department of Clinical Pharmacology
Vienna, Austria
Tear film thickness as measured with high resolution optical coherence tomography
Time frame: 4 weeks
Lipid layer thickness
Time frame: 4 weeks
Non-invasive tear break up time
Time frame: 4 weeks
Dynamic Meibomian Gland Imaging
Time frame: 4 weeks
Blink frequency
Time frame: 4 weeks
Symptom VAS
Time frame: 4 weeks
Corneal fluorescein staining
Time frame: 4 weeks
Conjunctival lissamine green staining
Time frame: 4 weeks
Schirmer I test
Time frame: 4 weeks
Tear film break up time
Time frame: 4 weeks
Ocular surface disease index
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.